639 related articles for article (PubMed ID: 18829477)
21. Progress in pharmacogenomics and its promise for medicine.
Blake CA; Sobel BE
Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537
[TBL] [Abstract][Full Text] [Related]
22. US FDA perspective on challenges in co-developing in vitro companion diagnostics and targeted cancer therapeutics.
Philip R; Carrington L; Chan M
Bioanalysis; 2011 Feb; 3(4):383-9. PubMed ID: 21338257
[TBL] [Abstract][Full Text] [Related]
23. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
Dilts DM; Sandler AB
J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693
[TBL] [Abstract][Full Text] [Related]
24. The trials and tribulations of drug development for functional gastrointestinal disorders.
Chang L
Neurogastroenterol Motil; 2008 May; 20 Suppl 1():130-8. PubMed ID: 18402650
[TBL] [Abstract][Full Text] [Related]
25. The ethics of phase 0 oncology trials.
Abdoler E; Taylor H; Wendler D
Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585
[TBL] [Abstract][Full Text] [Related]
26. [Molecule based diagnosis].
Akaza H; Ichikawa T; Tsuruo T; Shimada Y; Moriwaki H; Mori M; Noguchi S; Nakamura S; Saijo N; Sone S; Isonishi S; Ohashi Y; Hinotsu S; von Euler M; Blackedge G
Gan To Kagaku Ryoho; 2004 Jan; 31(1):125-33. PubMed ID: 14750337
[TBL] [Abstract][Full Text] [Related]
27. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
28. Discontinued drugs in 2008: oncology drugs.
Williams R
Expert Opin Investig Drugs; 2009 Nov; 18(11):1581-94. PubMed ID: 19663760
[TBL] [Abstract][Full Text] [Related]
29. Translating clinical trials into meaningful outcomes.
LoRusso PM; Schnipper LE; Stewart DJ; Boerner SA; Averbuch SD; Wolf W
Clin Cancer Res; 2010 Dec; 16(24):5951-5. PubMed ID: 21169247
[TBL] [Abstract][Full Text] [Related]
30. Cancer biomarkers--an invitation to the table.
Dalton WS; Friend SH
Science; 2006 May; 312(5777):1165-8. PubMed ID: 16728629
[TBL] [Abstract][Full Text] [Related]
31. Genomics: success or failure to deliver drug targets?
Betz UA; Farquhar R; Ziegelbauer K
Curr Opin Chem Biol; 2005 Aug; 9(4):387-91. PubMed ID: 15990354
[TBL] [Abstract][Full Text] [Related]
32. The development of genomics-derived pharmaceuticals.
Beardsley TM; Rosen CA; Stump DC
Curr Opin Drug Discov Devel; 2001 Mar; 4(2):186-91. PubMed ID: 11378957
[TBL] [Abstract][Full Text] [Related]
33. Biomarkers: a valuable tool in clinical research and medical practice.
Carini C
IDrugs; 2007 Jun; 10(6):395-8. PubMed ID: 17642003
[TBL] [Abstract][Full Text] [Related]
34. Oncology trials gear up for high-throughput sequencing.
Mullard A
Nat Rev Drug Discov; 2012 Apr; 11(5):339-40. PubMed ID: 22543457
[No Abstract] [Full Text] [Related]
35. Curtailing the high rate of late-stage attrition of investigational therapeutics against unprecedented targets in patients with lung and other malignancies.
Rowinsky EK
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4220s-4226s. PubMed ID: 15217962
[TBL] [Abstract][Full Text] [Related]
36. Synergy between medical informatics and bioinformatics: facilitating genomic medicine for future health care.
Martin-Sanchez F; Iakovidis I; Nørager S; Maojo V; de Groen P; Van der Lei J; Jones T; Abraham-Fuchs K; Apweiler R; Babic A; Baud R; Breton V; Cinquin P; Doupi P; Dugas M; Eils R; Engelbrecht R; Ghazal P; Jehenson P; Kulikowski C; Lampe K; De Moor G; Orphanoudakis S; Rossing N; Sarachan B; Sousa A; Spekowius G; Thireos G; Zahlmann G; Zvárová J; Hermosilla I; Vicente FJ
J Biomed Inform; 2004 Feb; 37(1):30-42. PubMed ID: 15016384
[TBL] [Abstract][Full Text] [Related]
37. Translating genomic biomarkers into clinically useful diagnostics.
Ginsburg GS; Haga SB
Expert Rev Mol Diagn; 2006 Mar; 6(2):179-91. PubMed ID: 16512778
[TBL] [Abstract][Full Text] [Related]
38. Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.
Mousses S; Kiefer J; Von Hoff D; Trent J
Oncogene; 2008 Dec; 27 Suppl 2():S58-66. PubMed ID: 19956181
[TBL] [Abstract][Full Text] [Related]
39. [Clinical research in Germany at the example of oncology].
Seufferlein T; Adler G
Onkologie; 2010; 33 Suppl 7():1-5. PubMed ID: 20926906
[TBL] [Abstract][Full Text] [Related]
40. A two-stage Bayesian design for co-development of new drugs and companion diagnostics.
Karuri SW; Simon R
Stat Med; 2012 May; 31(10):901-14. PubMed ID: 22238151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
